Sagility India Analyst Review May 2026
- May 20, 2026
- Posted by: Neeraj Pandey
- Category: News
This Sagility India analyst review for May 2026 covers the key data investors need for SAGILITY at its current price of Rs 40.90. Sagility India (NSE: SAGILITY) is a healthcare-focused business process services company with a market capitalisation of approximately Rs 18,000 crore, serving US health insurance payers and providers. The analyst consensus target of Rs 52 implies meaningful upside, and this Sagility India analyst review examines technical levels, business performance, valuation, and key risks that will determine whether SAGILITY achieves that target through FY27.
Click Here – Get Free Investment Predictions
Sagility India Company Snapshot May 2026
Sagility was carved out of Hinduja Global Solutions’ healthcare BPS business. Its AI-powered claims processing, revenue cycle management, and clinical management services for US health insurers provide recurring, dollar-denominated revenue. The table below summarises the key data referenced in this Sagility India analyst review.
| Parameter | Value |
|---|---|
| NSE Ticker | SAGILITY |
| Sector | IT Services – Healthcare BPO |
| CMP (May 2026) | Rs 40.90 |
| 52 Week High | Rs 57.89 |
| 52 Week Low | Rs 35.83 |
| Market Cap | Rs 18,000 Crore |
| Trailing P/E | 30x |
| Analyst Consensus Target | Rs 52 |
| Bull Case Target | Rs 65 |
| Bear Case Target | Rs 33 |
Analyst Insight in This Sagility India Analyst Review
Senior Research Analyst Ankit Jaiswal flags Sagility India as a stock to watch in May 2026. At Rs 40.90, Ankit Jaiswal identifies key support in the Rs 37 to Rs 39 band and resistance near Rs 43. He suggests watching Sagility India for a potential move toward Rs 52, subject to IT Services – Healthcare BPO sector momentum and Nifty 50 direction. Ankit Jaiswal’s view is one input in this Sagility India analyst review and does not constitute a trade recommendation.
Technical Analysis in This Sagility India Analyst Review
At Rs 40.90, SAGILITY is trading within its 52-week band of Rs 35.83 to Rs 57.89. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.
Near-term support is identified in the Rs 37 to Rs 39 band while resistance is seen in the Rs 43 to Rs 46 zone. A sustained move above Rs 43 could open the path toward the analyst consensus target of Rs 52.
Screen the best stocks on the Univest Screener.
Key Support and Resistance Levels
- Support Zone: Rs 37 to Rs 39 – investors tracking this Sagility India analyst review should watch for stabilisation or a bounce in this range as a potential accumulation signal for SAGILITY.
- Resistance Zone: Rs 43 to Rs 46 – a sustained close above Rs 43 would be a positive breakout signal worth flagging in this Sagility India analyst review.
- Medium-Term Target: The analyst consensus of Rs 52 represents the base-case upside scenario identified in this Sagility India analyst review.
Business Segment Analysis
Health Insurance Claims Processing (US Payers)
This is the primary revenue and margin driver for Sagility India, directly supporting the earnings trajectory toward the consensus target of Rs 52.
Revenue Cycle Management for US Hospitals
This segment adds scale and diversification to Sagility India’s business model and is a meaningful EPS contributor through FY27 and FY28.
Clinical Management and Care Navigation
This represents the medium-term growth frontier for Sagility India and a key re-rating catalyst for the stock over the next 12 to 24 months.
Valuation in This Sagility India Analyst Review
At Rs 40.90, Sagility India trades at a trailing P/E of 30x. This Sagility India analyst review presents three valuation scenarios: a bull case of Rs 65 on strong earnings delivery and sector tailwinds, a base case of Rs 52 at analyst consensus, and a bear case of Rs 33 if macro headwinds persist. Q1 FY27 results will be the first key checkpoint for this Sagility India analyst review.
| Scenario | Target Price | Key Condition |
|---|---|---|
| Bull Case | Rs 65 | Strong earnings delivery and sector re-rating |
| Base Case (Consensus) | Rs 52 | Moderate growth, analyst consensus estimate |
| Bear Case | Rs 33 | Earnings miss or macro headwinds |
Trade Outlook for Sagility India
Based on the technical and fundamental analysis in this Sagility India analyst review, investors might watch SAGILITY near the support zone of Rs 37 to Rs 39 for potential opportunities. A flag above Rs 43 could suggest improving momentum toward Rs 52. This article uses watch-and-flag language only and does not constitute a trade recommendation.
Key Risks for Sagility India in FY27
A well-rounded Sagility India analyst review must assess downside risks. Key risks for Sagility India include a macro slowdown affecting IT Services – Healthcare BPO sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in SAGILITY.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Conclusion: Sagility India Analyst Review Verdict for 2026
This Sagility India analyst review concludes that at Rs 40.90, SAGILITY offers a defined risk-reward with a consensus target of Rs 52. The 52-week range of Rs 35.83 to Rs 57.89 provides context on the current entry point. Use this Sagility India analyst review as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on SAGILITY.
Frequently Asked Questions: Sagility India Analyst Review 2026
What is the analyst target for Sagility India in 2026?
The analyst consensus target is Rs 52, with a bull case of Rs 65 and a bear case of Rs 33. Monitor Q1 FY27 earnings for confirmation as highlighted in this Sagility India analyst review.
Is Sagility India a good investment at Rs 40.90?
At Rs 40.90 with a P/E of 30x and a consensus target of Rs 52, this Sagility India analyst review is constructive for medium to long-term investors in the IT Services – Healthcare BPO sector. Always consult a SEBI-registered advisor before investing.
What is Sagility India’s 52-week high and low?
The 52-week high is Rs 57.89 and the 52-week low is Rs 35.83. At Rs 40.90, SAGILITY is positioned within this range as noted in this Sagility India analyst review.
What are the key risks for Sagility India?
Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the IT Services – Healthcare BPO sector as assessed in this Sagility India analyst review.
Where can I track live data for Sagility India?
Track Sagility India’s live price and analyst targets on the Univest Screener alongside professional financial advice to complement this Sagility India analyst review.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.
